Alebund Pharmaceuticals (Jiangsu) Limited (HKG:9637)
Hong Kong · Delayed Price · Currency is HKD 28.96
-1.00 (-3.34%)
Last updated: Jul 16, 2026, 10:39 AM HKT
HKG:9637 Revenue
In the year 2025, Alebund Pharmaceuticals (Jiangsu) had annual revenue of 30.56M CNY with 368.29% growth.
Revenue
30.56M CNY
Revenue Growth
+368.29%
P/S Ratio
299.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.18B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.56M | 24.03M | 368.29% |
| Dec 31, 2024 | 6.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition